Combined Holdings of Intellia Therapeutics (NTLA) - Updated Daily
Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
0% | $2.00b |
🏋️♀️Weight Rank Across All Funds | 🌏Country |
200 | 🇺🇸United States |
💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
$54.51 - ARKG$62.04 - ARKK | 0.18% |
Other ETFs That Hold NTLA
Research Notes and Commentary for NTLA
No Research Notes Found for NTLA